MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Olfactory discrimination differentiate drug-induced parkinsonism and Parkinson’s disease

    IH. Kwak, JJ. Lee, MS. Kim, SY. Kang, HI. Ma, YE. Kim (Anyang-si, Republic of Korea)

    Objective: In this study, we evaluated detailed differential features of olfactory function in PD and DIP. Background: DIP is common but it is challenging to…
  • 2023 International Congress

    Dietary protein redistribution influences the efficacy of levodopa/carbidopa intestinal gel (LCIG) infusion

    Y. Ben Mordechai, S. Israeli-Korn, O. Cohen, S. Hassin-Baer (Tel Hashomer, Israel)

    Objective: To compare levodopa/carbidopa intestinal gel (LCIG) with equally distributed dietary protein (Diet_EDP) versus restricted to twice daily (Diet_RP) and Mediterranean diet (Diet_M). Background: Levodopa…
  • 2023 International Congress

    Understanding the Mechanisms of Brain Dysfunction when Performing the Mental Rotation Task (MRT) in Stage 1 and Stage 2 EOPD using brain imaging

    J. Razzaque, B. Mullen, C. Dougherty, A. Cotton, D. Wagner, S. Ravi, K. Le, K. Iyer, M. Subramanian, J. Wang, K. Venkiteswaran, T. Subramanian, P. Eslinger (Toledo, USA)

    Objective: Our aim is to understand MRT abnormalities in PD using fMRI and whether it can be used as a clinical marker for disease progression…
  • 2023 International Congress

    Impact of non-pharmacological strategies on progression in Parkinson’s Disease and Cognitive Impairment.

    MAG. Medrano-Delgado, DR. Aguila-Godinez, MF. Ruiz-Mafud, LG. Lira-Juárez, EC. Santiago Delacruz, A. Domínguez-García, AJ. Hernández-Medrano, AY. Regalado-Mustafá, MF. Medina-Pérez, G. Hernandez-Armesto, K. Talavera-Laguna, A. Herrera-Ruiz, J. García-Hernández, DP. Romero-Terán, A. Alcocer-Salas, G. Cerda-Hernández, A. Abundes-Corona, M. Rodríguez-Violante, A. Cervantes-Arriaga (Ciudad de Mexico, Mexico)

    Objective: to determine the Impact of non-pharmacological strategies on progression in Parkinson's Disease and Cognitive Impairment. Background: PD is the second most common neurodegenerative disorder,…
  • 2023 International Congress

    Use of stimview technology in deep brain stimulation of Parkinson´s disease patients

    A. Rodríguez-Sanz, S. Serrano López, B. Mansilla, M. Román, JF. Paz (Madrid, Spain)

    Objective: We present our experience of Stimview technology in the neurostimulation of 5 patients with Parkinson´s disease (PD). Background: It is common to make adjustments…
  • 2023 International Congress

    Parkinson’s disease (PD) progression is associated with past exposure to organic contaminants in water at Marine Corps Base Camp Lejeune

    S. Goldman, F. Weaver, B. Gonzalez, K. Stroupe, L. Cao, K. Colletta, E. Brown, C. Tanner (San Francisco, USA)

    Objective: To test whether PD progression is more rapid in individuals who were exposed to volatile organic compounds in the water supply at Camp Lejeune…
  • 2023 International Congress

    Hypnosis for Deep Brain Stimulator Surgery

    I. Cohen, D. Englert, M. Henegar, J. Rayner, K. Gamble, S. Patel (Charlotte, USA)

    Objective: To describe the use of hypnosis as an adjunct to local anesthetic during placement of deep brain stimulator (DBS) Background: DBS has become commonplace…
  • 2023 International Congress

    Foslevodopa/foscarbidopa subcutaneous infusion shows similar infusion site reaction severity score across range of infusion rates in patients with Parkinson’s disease

    L. Schlachter, S. Stodtmann, S. Talapala, M. Facheris, M. Rosebraugh (Ludwigshafen, Germany)

    Objective: Characterize the relationship between foslevodopa/foscarbidopa infusion rate and infusion site reaction (ISR) score in patients with Parkinson’s disease (PD) Background: As PD progresses, motor…
  • 2023 International Congress

    Neuromelanin related 7T MRI of the locus coeruleus differs between Parkinson’s disease and controls

    A. Wolters, M. Heijmans, N. Priovoulos, H. Jacobs, A. Postma, Y. Temel, M. Kuijf, S. Michielse (Maastricht, Netherlands)

    Objective: To compare the signal intensity of the substantia nigra and locus coeruleus on Magnetization Transfer 7T MRI between PD patients and healthy controls (HC)…
  • 2023 International Congress

    IP-RT-QuIC Identify Disease-Specific Alpha-Synuclein Seeds in serum from patients with syncleinopathy

    A. Okuzumi, T. Hatano, G. Matsumoto, N. Hattori (Tokyo, Japan)

    Objective: To examine whether alpha-synuclein (aSyn) seed exists in the serum and its potential as a serum biomarker. Background: Parkinson’s disease (PD) and Multiple system…
  • « Previous Page
  • 1
  • …
  • 270
  • 271
  • 272
  • 273
  • 274
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley